Streptococcus Pneumoniae IgG Antibody Panel
This blood test panel measures IgG antibodies to multiple pneumococcal serotypes to assess vaccine response, immune function patterns, and documentation needs.
This panel bundles multiple biomarker tests in one order—your report explains how results fit together.
This is a lab panel, not a single number. The Streptococcus pneumoniae (pneumococcus) IgG Antibody Panel measures your IgG antibody levels to multiple pneumococcal serotypes (strains) in one blood draw. Looking at the pattern across serotypes can help document vaccine response, clarify whether your immune system is making protective antibodies, and guide next steps when you have recurrent respiratory infections or need proof of immunity by a deadline.
Do I need this panel?
You may consider this panel if you have frequent or hard-to-shake respiratory infections (sinus infections, ear infections, bronchitis, or pneumonia), especially when infections cluster over time or require repeated antibiotics. Pneumococcal antibody titers are one way to check whether your immune system is producing effective, targeted antibodies against a common cause of bacterial pneumonia.
This panel is also commonly used when you need vaccine titer documentation for school, work, or clinical clearance, or when your clinician is evaluating possible humoral (antibody-mediated) immune dysfunction such as specific antibody deficiency. It can be ordered before and/or after pneumococcal vaccination to assess response.
If you are dealing with chronic fatigue or post-viral symptoms, this panel does not diagnose a cause by itself, but it can add useful context—particularly if you have a history of recurrent infections or you are trying to understand whether immune protection is robust or patchy.
Your results should be interpreted alongside your symptoms, vaccine history, and other labs. This panel supports clinician-directed care and shared decision-making; it is not a stand-alone diagnosis.
This panel measures serotype-specific Streptococcus pneumoniae IgG antibodies in blood; reference ranges and “protective” thresholds can vary by lab and clinical context.
Lab testing
Order labs to measure Streptococcus pneumoniae IgG Antibody Panel
from $631.37 at Quest Diagnostics
About 1 week
Schedule online — results typically within a week
Clear next steps
Guidance included, with follow-up care available
HSA / FSA
Eligible for pre-tax health spending accounts
Get this panel with Vitals Vault
Vitals Vault makes it straightforward to order a pneumococcal IgG antibody panel when you need a clear, multi-serotype snapshot rather than a single antibody result. You can use this panel for baseline assessment, for documentation needs, or to help you and your clinician evaluate whether your antibody responses look broad and consistent.
After you receive results, PocketMD can help you understand the overall pattern across serotypes—what looks strong, what looks borderline, and what may warrant follow-up—so you can have a more productive conversation with your clinician. This is especially helpful when you are trying to interpret mixed results (some serotypes high, others low) or when you are comparing pre- and post-vaccine titers.
If you are on a timeline (school or workplace forms), ordering a single panel that bundles multiple serotype titers can be simpler than piecing together separate tests. If follow-up testing is recommended, you can also use Vitals Vault to repeat the same panel for trend comparison.
- One blood draw to assess multiple pneumococcal serotype IgG titers
- Results you can review in context (vaccine timing, infection history, and related immune labs)
- PocketMD support for pattern-based interpretation and next-step questions to ask
Key benefits of the Streptococcus Pneumoniae IgG Antibody Panel
- Checks immunity across multiple pneumococcal serotypes instead of relying on a single antibody result.
- Helps document vaccine response when you need proof of immunity for school, work, or clinical requirements.
- Supports evaluation of recurrent sinus, ear, and lower respiratory infections where pneumococcus is a common culprit.
- Identifies “patchy” antibody patterns that can suggest reduced functional antibody response despite normal total IgG.
- Guides whether pre- and post-vaccination titer comparison could be useful for immune workups.
- Adds context to chronic fatigue or post-viral investigations when infection susceptibility is part of your story.
- Creates a baseline you can repeat to track changes after vaccination, treatment, or time.
What is the Streptococcus Pneumoniae IgG Antibody Panel?
The Streptococcus pneumoniae IgG Antibody Panel is a blood test panel that measures IgG antibodies directed against multiple pneumococcal serotypes. Streptococcus pneumoniae is a bacterium that can cause pneumonia, sinusitis, otitis media (middle ear infection), and invasive disease in higher-risk situations.
IgG antibodies are part of your adaptive immune system. After vaccination or exposure, your immune system can produce serotype-specific antibodies that recognize the polysaccharide capsule of pneumococcus. Because pneumococcus has many serotypes, protection is not “all-or-nothing.” You can have strong antibodies to some serotypes and weaker antibodies to others.
This panel is often used in two main ways:
1) Vaccine response assessment: If you have received pneumococcal vaccination (such as conjugate or polysaccharide vaccines), serotype-specific IgG levels can help show whether your immune system mounted a response. In some clinical workflows, titers are measured before vaccination and again several weeks after vaccination to evaluate response.
2) Immune function patterning: If you have recurrent infections, clinicians may look for patterns consistent with impaired specific antibody production (sometimes discussed as “specific antibody deficiency”), especially when total immunoglobulin levels are normal but functional responses to certain vaccines appear suboptimal.
A key point: this is a panel with multiple results. The interpretation usually focuses on the overall distribution of serotype titers (how many are above a lab’s protective threshold, how many are low, and whether the pattern fits your vaccine history), rather than any single serotype in isolation.
What do my panel results mean?
When many serotype titers are low
If a large share of serotype-specific IgG results are low (or below a lab’s stated protective threshold), it can suggest limited antibody protection against pneumococcus—especially if this matches your history of recurrent respiratory infections. This pattern may be seen when you have not been vaccinated, when testing is done too soon after vaccination to capture a mature response, or when your immune system has difficulty producing effective antibodies to polysaccharide antigens. Your clinician may consider your vaccine timeline, total immunoglobulins, and other immune markers to decide whether repeat testing (often post-vaccine) or additional immune evaluation is appropriate.
When titers are broadly protective across serotypes
If your results show protective or robust IgG levels across many serotypes, that pattern generally supports adequate humoral immunity to pneumococcus. In practical terms, it can make pneumococcal-specific antibody deficiency less likely as an explanation for frequent infections. If you are using the panel for documentation, a broadly protective pattern can also help satisfy requirements, though the exact documentation standard depends on the requesting institution. Even with strong titers, infections can still occur due to viral triggers, non-pneumococcal bacteria, airway inflammation, or exposure intensity, so the panel is best viewed as one piece of the overall picture.
When some or many titers are high
Higher serotype-specific IgG levels often reflect prior vaccination and/or past exposure, and they are not usually a problem by themselves. A pattern where many serotypes are high may be expected after recent vaccination, while a mixed pattern (some high, some low) can occur because vaccines cover specific serotypes and because immune responses vary by serotype. If you are comparing pre- and post-vaccine results, the key question is often whether there is a meaningful rise in multiple serotypes rather than whether one value is “very high.” Your clinician may focus on breadth of response, not just magnitude.
Factors that influence pneumococcal IgG titers
Timing matters: titers can be lower before vaccination and may rise over weeks after vaccination, then gradually change over time. Vaccine type and history also matter because different pneumococcal vaccines cover different serotypes and can produce different response patterns. Age, immune-modulating medications (including some steroids or biologics), certain chronic conditions, and underlying immune disorders can affect antibody production. Lab methods and reference thresholds vary, so it is important to interpret results using the lab’s ranges and in the context of why you tested (documentation vs immune evaluation). If you have low titers alongside low total IgG or other abnormal immune labs, the interpretation and next steps may differ from isolated low pneumococcal titers.
What’s included in this panel
- Serotype 1 (1)
- Serotype 12 (12f)
- Serotype 14 (14)
- Serotype 19 (19f)
- Serotype 23 (23f)
- Serotype 26 (6b)
- Serotype 3 (3)
- Serotype 4 (4)
- Serotype 5 (5)
- Serotype 51 (7f)
- Serotype 56 (18c)
- Serotype 68 (9v)
- Serotype 8 (8)
- Serotype 9 (9n)
Similar tests and panels to consider
Frequently Asked Questions
Do I need to fast for the Streptococcus Pneumoniae IgG Antibody Panel?
Fasting is not typically required for pneumococcal IgG antibody titers because the test measures antibodies rather than glucose or lipids. If you are combining this panel with other labs that require fasting, follow the instructions for the full set of tests you ordered.
How is this panel different from a single “pneumococcal antibody” test?
This is a panel with multiple serotype-specific IgG results. A single, non-specific pneumococcal antibody result may not capture whether your immunity is broad across vaccine-covered serotypes. Clinicians often rely on the pattern across many serotypes to assess vaccine response or functional antibody production.
What does IgG mean, and how is it different from IgM?
IgG is an antibody class that usually reflects longer-term immune memory from past exposure or vaccination. IgM is more associated with early or acute immune responses. Pneumococcal serology for vaccine response is typically focused on IgG serotype titers, not IgM.
Can I use this panel to prove I had pneumonia recently?
Not reliably. Pneumococcal IgG titers are mainly used to assess immunity and vaccine response, not to diagnose an acute infection. If you are trying to evaluate a current respiratory illness, tests like respiratory PCR panels, cultures, or antigen testing (depending on setting) are usually more relevant.
When should I test after a pneumococcal vaccine?
For vaccine response assessment, clinicians often compare a pre-vaccine baseline to a post-vaccine sample collected several weeks later. The ideal timing depends on the vaccine type, your clinical situation, and the lab’s guidance. If you test too soon, the rise in titers may be incomplete.
Why are some serotypes high and others low?
Mixed patterns are common. Vaccines cover specific serotypes, and immune responses can vary by serotype. Past exposures, time since vaccination, and individual immune variability can all create a “patchy” pattern. Interpretation usually focuses on how many serotypes reach protective thresholds and whether the pattern fits your vaccine history.
Should I order total immunoglobulins along with this panel?
It can be helpful. Total immunoglobulins (IgG, IgA, IgM, sometimes IgE) provide a broader view of antibody quantity, while this panel looks at pneumococcal antibody specificity. If your pneumococcal titers are low, total immunoglobulins can help clarify whether the issue is overall low antibody levels or a more specific functional response pattern.